相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitochondrial Reactive Oxygen Species and Mitophagy: A Complex and Nuanced Relationship
James H. Schofield et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Modulation of Interleukin-1 and-18 Mediated Injury in Donation after Circulatory Death Mouse Hearts
Mohammed Quader et al.
JOURNAL OF SURGICAL RESEARCH (2021)
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure
George F. Wohlford et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2021)
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the adapted pathogen Salmonella Typhimurium due to site-specific bacterial PAMP expression
Annika Hausmann et al.
MUCOSAL IMMUNOLOGY (2020)
Purinergic signaling, DAMPs, and inflammation
Francesco Di Virgilio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Antonio Abbate et al.
CIRCULATION RESEARCH (2020)
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction
Antonio Abbate et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Precisely and Efficiently Enzyme Response Microspheres with Immune Removal Escape Loaded with MCC950 Ameliorate Cardiac Dysfunction in Acute Myocardial Infarction
Panke Cheng et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2020)
Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury
Sean M. Davidson et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Involvement of exchange protein directly activated by cAMP and tumor progression locus 2 in IL-1β production in microglial cells following activation of β-adrenergic receptors
Hidetoshi Tozaki-Saitoh et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)
Effects of irbesartan on myocardial injury in diabetic rats: The role of NLRP3/ASC/Caspase-1 pathway
Li Rong et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2020)
Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice
Pingping Ren et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
Cheng Zeng et al.
REDOX BIOLOGY (2020)
Targeting the NLRP3 inflammasome to reduce warm ischemic injury in donation after circulatory death heart
Mohammed Quader et al.
CLINICAL TRANSPLANTATION (2020)
Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis
Suwen Chen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Macrophage-NLRP3 Inflammasome Activation Exacerbates Cardiac Dysfunction after Ischemic Stroke in a Mouse Model of Diabetes
Hong-Bin Lin et al.
NEUROSCIENCE BULLETIN (2020)
MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation
Maorong Jiang et al.
JOURNAL OF NEUROINFLAMMATION (2020)
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease
Niklas Lonnemann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
Viola Kluck et al.
LANCET RHEUMATOLOGY (2020)
Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis
Amalie Vromman et al.
EUROPEAN HEART JOURNAL (2019)
Nebivolol Improves Obesity-Induced Vascular Remodeling by Suppressing NLRP3 Activation
Jing Gao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
MCC950 directly targets the NLRP3 ATP- hydrolysis motif for inflammasome inhibition
Rebecca C. Coll et al.
NATURE CHEMICAL BIOLOGY (2019)
NLRP3 inhibition improves heart function in GPER knockout mice
Hao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
The NLRP3 Inflammasome as a Pharmacological Target
Carlo Marchetti
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction
Rifeng Gao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
Lieselotte Vande Walle et al.
PLOS BIOLOGY (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
Alba Sanchez-Fernandez et al.
FRONTIERS IN IMMUNOLOGY (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
IL-18 cleavage triggers cardiac inflammation and fibrosis upon beta-adrenergic insult
Han Xiao et al.
EUROPEAN HEART JOURNAL (2018)
Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation
Mariela Castelblanco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo et al.
NATURE REVIEWS CARDIOLOGY (2018)
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein
Cory R. Trankle et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function
Jonathon P. Audia et al.
BASIC RESEARCH IN CARDIOLOGY (2018)
The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
Wenqiang Gan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
Chunxia Yao et al.
CIRCULATION (2018)
Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
Yi Huang et al.
EMBO MOLECULAR MEDICINE (2018)
Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization
Jacob Fulp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Macrophage Uptake of Necrotic Cell DNA Activates the AIM2 Inflammasome to Regulate a Proinflammatory Phenotype in CKD
Takanori Komada et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Luis E. Pavillard et al.
PHARMACOLOGICAL RESEARCH (2018)
OLT1177, a ß-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Carlo Marchetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome A CT Coronary Angiography Study
Kaivan Vaidya et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Inflammasome Priming Mediated via Toll-Like Receptors 2 and 4, Induces Th1-Like Regulatory T Cells in De Novo Autoimmune Hepatitis
Adam S. Arterbery et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
Stefano Toldo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2018)
Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target
Teresa Pasqua et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Pretreatment with low-dose fimasartan ameliorates NLRP3 inflammasome-mediated neuroinflammation and brain injury after intracerebral hemorrhage
Xiuli Yang et al.
EXPERIMENTAL NEUROLOGY (2018)
New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
Zhenyu Zhong et al.
NATURE (2018)
Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
Takeshi Suetomi et al.
CIRCULATION (2018)
An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet-Induced Cardiac Dysfunction in Mice
Salvatore Carbone et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
Cryo-EM structures of ASC and NLRC4 CARD filaments reveal a unified mechanism of nucleation and activation of caspase-1
Yang Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis
Carlo Marchetti et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Cathepsin B-Mediated NLRP3 Inflammasome Formation and Activation in Angiotensin II -Induced Hypertensive Mice: Role of Macrophage Digestion Dysfunction
Dawei Lian et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
CaMKII delta-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis
Andrew Willeford et al.
JCI INSIGHT (2018)
The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
Gerardus P. J. van Hout et al.
EUROPEAN HEART JOURNAL (2017)
Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 Alpha
Adolfo G. Mauro et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
The Highly Selective Caspase-1 Inhibitor VX-765 Provides Additive Protection Against Myocardial Infarction in Rat Hearts When Combined With a Platelet Inhibitor
Xi-Ming Yang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Hua Jiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Inflammasome and Autophagy Regulation: A Two-way Street
Qian Sun et al.
MOLECULAR MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats
Zhen Qiu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction
Luis E. Pavillard et al.
ONCOTARGET (2017)
TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
Naif Mohammad Alhawiti et al.
CURRENT DRUG TARGETS (2017)
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2017)
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report
Thomas van der Heijden et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction
Koichiro Fujisue et al.
CIRCULATION JOURNAL (2017)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic Syndrome
Andrew J. Murphy et al.
CELL METABOLISM (2016)
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors
Mattia Cocco et al.
CHEMMEDCHEM (2016)
Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse
Stefano Toldo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction
Peter C. Westman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Xing Liu et al.
NATURE (2016)
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
Yuan He et al.
NATURE (2016)
Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways
Raffaella Mastrocola et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
The emerging role of Toll-like receptor 4 in myocardial inflammation
Y. Yang et al.
CELL DEATH & DISEASE (2016)
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Structural Biology of Innate Immunity
Qian Yin et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
The Inflammasome in Myocardial Injury and Cardiac Remodeling
Stefano Toldo et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
Hendrik B. Sager et al.
CIRCULATION (2015)
Danger Signaling in Atherosclerosis
Sebastian Zimmer et al.
CIRCULATION RESEARCH (2015)
Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
Carlo Marchetti et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Tranilast: A review of its therapeutic applications
Sara Darakhshan et al.
PHARMACOLOGICAL RESEARCH (2015)
Hydrogen sulfide and cardioprotection - Mechanistic insights and clinical translatability
Fadi N. Salloum
PHARMACOLOGY & THERAPEUTICS (2015)
NOD-LIKE RECEPTORS: VERSATILE CYTOSOLIC SENTINELS
Vinicius Motta et al.
PHYSIOLOGICAL REVIEWS (2015)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
The protective role of interleukin-18 binding protein in a murine model of cardiac ischemia/reperfusion injury
Haifeng Gu et al.
TRANSPLANT INTERNATIONAL (2015)
Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease
Lisa M. Mullen et al.
ARTHRITIS RESEARCH & THERAPY (2015)
NADPH Oxidase-Induced NALP3 Inflammasome Activation Is Driven by Thioredoxin-Interacting Protein Which Contributes to Podocyte Injury in Hyperglycemia
Pan Gao et al.
JOURNAL OF DIABETES RESEARCH (2015)
Reactive oxygen species and mitochondria: A nexus of cellular homeostasis
Joe Dan Dunn et al.
REDOX BIOLOGY (2015)
IL-18 neutralization during alveolar hypoxia improves left ventricular diastolic function in mice
V. Hillestad et al.
ACTA PHYSIOLOGICA (2015)
Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart
Stefano Toldo et al.
CARDIOVASCULAR RESEARCH (2015)
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
Allison C. Morton et al.
EUROPEAN HEART JOURNAL (2015)
Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
Benjamin Wallace Van Tassell et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Production and Physiological Effects of Hydrogen Sulfide
Hideo Kimura
ANTIOXIDANTS & REDOX SIGNALING (2014)
TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
Yi Liu et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
Induction of MicroRNA-21 With Exogenous Hydrogen Sulfide Attenuates Myocardial Ischemic and Inflammatory Injury in Mice
Stefano Toldo et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Interleukin-1β Blockade Improves Left Ventricular Systolic/Diastolic Function and Restores Contractility Reserve in Severe Ischemic Cardiomyopathy in the Mouse
Stefano Toldo et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia-Reperfusion in the Mouse
Carlo Marchetti et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
Inflammasome Priming by Lipopolysaccharide Is Dependent upon ERK Signaling and Proteasome Function
Mohammed G. Ghonime et al.
JOURNAL OF IMMUNOLOGY (2014)
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis
Mattia Cocco et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction
Ignacio M. Seropian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Interleukin-18 as a Therapeutic Target in Acute Myocardial Infarction and Heart Failure
Laura C. O'Brien et al.
MOLECULAR MEDICINE (2014)
Elevated Plasma IL-37, IL-18, and IL-18BP Concentrations in Patients with Acute Coronary Syndrome
Qingwei Ji et al.
MEDIATORS OF INFLAMMATION (2014)
Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
Yongliang Wang et al.
CARDIOLOGY (2013)
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemiareperfusion injury
Oystein Sandanger et al.
CARDIOVASCULAR RESEARCH (2013)
Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death
Heriberto Lima et al.
CELL CYCLE (2013)
Targeting Interleukin-1 in Heart Disease
Benjamin W. Van Tassell et al.
CIRCULATION (2013)
Association of nucleotide-binding oligomerization domain-like receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy
Beibei Luo et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Interleukin-1 blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse
Stefano Toldo et al.
EXPERIMENTAL PHYSIOLOGY (2013)
Early and Delayed Tranilast Treatment Reduces Pathological Fibrosis Following Myocardial Infarction
Fiona See et al.
HEART LUNG AND CIRCULATION (2013)
Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
Shankar S. Iyer et al.
IMMUNITY (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
Benedicte F. Py et al.
MOLECULAR CELL (2013)
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
Takuma Misawa et al.
NATURE IMMUNOLOGY (2013)
Macrophages in atherosclerosis: a dynamic balance
Kathryn J. Moore et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
An Exogenous Hydrogen Sulphide Donor, NaHS, Inhibits the Nuclear Factor κB Inhibitor Kinase/Nuclear Factor κB Inhibitor/Nuclear Factor-κB Signaling Pathway and Exerts Cardioprotective Effects in a Rat Hemorrhagic Shock Model
Cao Gao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Recombinant Human Interleukin-1 Receptor Antagonist Provides Cardioprotection During Myocardial Ischemia Reperfusion in the Mouse
Stefano Toldo et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
Christine Juliana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Regulation of inflammasome signaling
Vijay A. K. Rathinam et al.
NATURE IMMUNOLOGY (2012)
Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
Benjamin W. Van Tassell et al.
PLOS ONE (2012)
Colchicine for Recurrent Pericarditis (CORP) A Randomized Trial A Randomized Trial
Massimo Imazio et al.
ANNALS OF INTERNAL MEDICINE (2011)
Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
Masanori Kawaguchi et al.
CIRCULATION (2011)
Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 Inflammasome In Vitro
Borbala Pazar et al.
JOURNAL OF IMMUNOLOGY (2011)
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
Eleonora Mezzaroma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Interleukin-1β modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
Antonio Abbate et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
BAY 11-7082, a Nuclear Factor-κB Inhibitor, Reduces Inflammation and Apoptosis in a Rat Cardiac Ischemia-Reperfusion Injury Model
Yong Sook Kim et al.
INTERNATIONAL HEART JOURNAL (2010)
Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
Christine Juliana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Interleukin-1 Trap Attenuates Cardiac Remodeling After Experimental Acute Myocardial Infarction in Mice
Benjamin W. Van Tassell et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Toll-like receptors and innate immunity
Himanshu Kumar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
Mihai G. Netea et al.
BLOOD (2009)
Anakinra in Experimental Acute Myocardial Infarction-Does Dosage or Duration of Treatment Matter?
Fadi N. Salloum et al.
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Trine H. Mogensen
CLINICAL MICROBIOLOGY REVIEWS (2009)
INFLAMMASOMES ARE DIFFERENTIALLY EXPRESSED IN CARDIOVASCULAR AND OTHER TISSUES
Y. Yin et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury
Kaliyamurthi Venkatachalam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
Cholesterol-dependent cytolysins induce rapid release of mature IL-1β from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner
Jessica Chu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors
Antero Salminen et al.
PROGRESS IN NEUROBIOLOGY (2009)
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
Antonio Abbate et al.
CIRCULATION (2008)
The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock
Wei Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy
Darren J. Kelly et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
V. Petrilli et al.
CELL DEATH AND DIFFERENTIATION (2007)
Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty
Ali A. Youssef et al.
CIRCULATION JOURNAL (2007)
The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation
Ivan Tattoli et al.
SEMINARS IN IMMUNOPATHOLOGY (2007)
Cryopyrin activates the inflammasome in response to toxins and ATP
S Mariathasan et al.
NATURE (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
The HIN-200 family: More than interferon-inducible genes?
LEA Ludlow et al.
EXPERIMENTAL CELL RESEARCH (2005)
Increased circulating interleukin-18 in patients with congestive heart failure
Y Naito et al.
HEART (2002)
Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β
BJ Pomerantz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
